These Analysts Revise Their Forecasts On Alibaba After Q2 Results — Positive

BABA   Benzinga — November 26, 2025

Alibaba Group Holding (NYSE: BABA) posted better-than-expected second-quarter results on Tuesday.

image for news These Analysts Revise Their Forecasts On Alibaba After Q2 Results

Plug Power vs. Flux Power: Which Clean Energy Stock Has the Edge? — Neutral

FLUX  PLUG   Zacks Investment Research — November 26, 2025

PLUG's rising electrolyzer demand contrasts with FLUX's order declines, sharpening the clean-energy battle for investors.

image for news Plug Power vs. Flux Power: Which Clean Energy Stock Has the Edge?

Roper's Application Software Strength Holds Firm: More Upside Ahead? — Positive

ROP   Zacks Investment Research — November 26, 2025

ROP's Application Software segment surges on SaaS demand, enterprise wins and retention, setting up mid-single-digit growth ahead.

image for news Roper's Application Software Strength Holds Firm: More Upside Ahead?

Battle of Benefits: Will UNH Deliver the Bigger Dose or CVH? — Positive

CVS  UNH   Zacks Investment Research — November 26, 2025

CVS's rising margins, stronger guidance and sharper valuation edge make it stand out in the UNH vs. CVS upside debate.

image for news Battle of Benefits: Will UNH Deliver the Bigger Dose or CVH?

NEW YORK, Nov. 26, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against MoonLake Immunotherapeutics (“MoonLake” or “the Company”) (NASDAQ: MLTX) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired MoonLake securities between March 10, 2024 and September 29, 2025, both dates inclusive (the “Class Period”).

image for news MLTX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that MoonLake Immunotherapeutics Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

TowneBank Announces Quarterly Cash Dividend — Neutral

TOWN   GlobeNewsWire — November 26, 2025

SUFFOLK, Va., Nov. 26, 2025 (GLOBE NEWSWIRE) -- Hampton Roads based TowneBank (NASDAQ: TOWN) announced today that its Board of Directors declared its fourth-quarter shareholder cash dividend of $0.27 per common share payable on January 7, 2026, to shareholders of record on December 26, 2025.

image for news TowneBank Announces Quarterly Cash Dividend

SMX: The Day Gold Ran Out of Hiding and Why It Never Will Again — Neutral

SMX   Accesswire — November 26, 2025

NEW YORK, NY / ACCESS Newswire / November 26, 2025 / Dubai is where gold goes when it needs legitimacy. It is where traders settle disputes, where refineries validate origin, where vaults defend their reputation, and where markets turn when they want to know what the future of bullion looks like.

image for news SMX: The Day Gold Ran Out of Hiding and Why It Never Will Again

Autodesk Stock Jumps on Strong Results, Upbeat Forecast — Positive

ADSK   Schaeffers Research — November 26, 2025

Autodesk Inc (NASDAQ:ADSK) stock is on the rise today, up 4.7% at $308.35 at last glance, after the company posted better-than-expected third-quarter results, with earnings of $2.67 per share on revenue of $1.85 billion.

image for news Autodesk Stock Jumps on Strong Results, Upbeat Forecast

ConocoPhillips or ExxonMobil: Which Oil Major Looks Stronger Today? — Positive

COP  XOM   Zacks Investment Research — November 26, 2025

XOM's integrated strength and low-cost assets contrast with COP's upstream focus as investors weigh stability versus risk.

image for news ConocoPhillips or ExxonMobil: Which Oil Major Looks Stronger Today?

Strength in Aerospace Segment Drives Honeywell: Can the Momentum Sustain? — Positive

HON   Zacks Investment Research — November 26, 2025

HON's aerospace strength accelerates with surging commercial aftermarket and steady defense demand, driving Q3 gains.

image for news Strength in Aerospace Segment Drives Honeywell: Can the Momentum Sustain?

Nu vs. OppFi: Which Fintech Lender Offers Better Upside Now? — Positive

NU  OPFI   Zacks Investment Research — November 26, 2025

OPFI and NU post strong Q3 gains, with rising demand, sharper profitability and expanding credit driving the fintech face-off.

image for news Nu vs. OppFi: Which Fintech Lender Offers Better Upside Now?

Super Micro: Oversold, Just Above Strong Support Level — Positive

SMCI   Seeking Alpha — November 26, 2025

Super Micro Computer has experienced significant volatility recently, dropping from $60 to near $30, a key support level. In addition to being just above a strong support level of $30, SMCI is also massively oversold. Despite a notable FY2026 revenue guidance boost, the stock's recent price movement leaves it massively undervalued, with its P/S ratio near crisis levels.

image for news Super Micro: Oversold, Just Above Strong Support Level

Workday Tumbles as Subscription Revenue Disappoints — Negative

WDAY   Schaeffers Research — November 26, 2025

Workday Inc (NASDAQ:WDAY) is down 7.6% to trade at $215.90, despite posting better-than-expected third-quarter results after Tuesday's close.

image for news Workday Tumbles as Subscription Revenue Disappoints

Primoris Services vs. MasTec: Which Construction Stock to Bet on Now? — Positive

MTZ  PRIM   Zacks Investment Research — November 26, 2025

The robust public infrastructure spending environment is benefiting firms operating in the infrastructure and specialty-construction markets focused on utilities, energy, pipeline and heavy civil projects. Companies like Primoris Services Corporation PRIM and MasTec, Inc. MTZ are a few names that are leveraging the incremental market trends.

image for news Primoris Services vs. MasTec: Which Construction Stock to Bet on Now?

NOC Secures a Contract to Aid Stand-In Attack Weapon Subsystem — Neutral

NOC   Zacks Investment Research — November 26, 2025

Northrop Grumman lands a $100M contract to advance Stand-in Attack Weapon work, bolstering active-seeker development and strike capabilities.

image for news NOC Secures a Contract to Aid Stand-In Attack Weapon Subsystem

Big Banks Poised to Capitalize on Fixed-Income Trading Surge — Positive

BAC  GS  JPM   Zacks Investment Research — November 26, 2025

JPM, BofA and GS stand to gain as surging fixed-income trading, fueled by rate shifts and steepening yield curve, lifts revenue prospects.

image for news Big Banks Poised to Capitalize on Fixed-Income Trading Surge

NuScale Power's ENTRA1 Deal Deepens: Can it Deliver 6GW by 2030? — Negative

SMR   Zacks Investment Research — November 26, 2025

SMR's 6GW plan with ENTRA1 advances with major milestone payments, but TVA reviews and PPA delays still threaten the 2030 timeline.

image for news NuScale Power's ENTRA1 Deal Deepens: Can it Deliver 6GW by 2030?

AbbVie and Pfizer: A Closer Look at Two Pharma Heavyweights — Positive

ABBV  PFE   Zacks Investment Research — November 26, 2025

ABBV's surging immunology sales and smoother LOE path stand out as both drugmakers face a pivotal 2026.

image for news AbbVie and Pfizer: A Closer Look at Two Pharma Heavyweights

NVO Stock Up as Amycretin Shows Strong Weight Loss in Type 2 Diabetes — Neutral

NVO   Zacks Investment Research — November 26, 2025

Novo Nordisk jumps after phase II data show amycretin offers significant weight loss and HbA1c level reductions in type 2 diabetes patients.

image for news NVO Stock Up as Amycretin Shows Strong Weight Loss in Type 2 Diabetes

Market Participants Thankful Ahead of the Open — Positive

DE   Zacks Investment Research — November 26, 2025

Pre-market futures are in the green again this hour and holding steady through the release of a few key pieces of data this morning.

image for news Market Participants Thankful Ahead of the Open